Upon joining the study, the child will be assigned to receive one of two sedation medications through intravenous infusion, which means the medication will be delivered directly into a vein through a continuous drip.

The child will receive either dexmedetomidine or midazolam as the main sedation medication. Dexmedetomidine is given at a concentration of 100 micrograms per milliliter, while midazolam is given at a concentration of 1 milligram per milliliter.

At the time of entering the study, the child should have been receiving sedation with benzodiazepines for less than 6 hours.

Throughout the stay in the pediatric intensive care unit, the child’s sedation level will be assessed every 4 hours using the COMFORT B scale, which is a measurement tool that helps determine if the sedation level is appropriate.

The medical team will monitor whether the child is receiving the correct amount of sedation, ensuring the child is neither too deeply sedated nor insufficiently sedated.

Delirium is a state of confusion that can occur in critically ill children. The child will be regularly evaluated for delirium using the CAPD scale, which is a specific assessment tool for pediatric delirium.

A CAPD score of 9 or higher indicates the presence of delirium. The medical team will record any episodes of delirium that occur during the intensive care stay.

The number of days with delirium symptoms will be documented throughout the treatment period.

If needed, the child may receive additional sedative medications such as benzodiazepines, ketamine, or propofol, as well as opioids for pain management.

The daily amounts of these medications will be calculated based on the child’s weight and recorded.

If severe delirium occurs, the child may be given antipsychotic drugs to help manage the symptoms.

The child will remain on mechanical ventilation, which is a machine that helps with breathing. This is expected to last for more than 12 hours.

The total time the child spends on mechanical ventilation will be measured in hours.

Once the child’s condition improves, the breathing tube will be removed in a process called extubation. The medical team will monitor whether the child needs to be placed back on the ventilator after the tube is removed.

Throughout the treatment, the medical team will monitor for potential side effects including hypotension, which is low blood pressure, and bradycardia, which is a slower than normal heart rate.

The team will also watch for accidental removal of medical equipment, such as the breathing tube or central line, which is a special intravenous catheter.

If necessary, brain imaging or an electroencephalogram, which is a test that measures electrical activity in the brain, may be performed.

As sedation medications are reduced or stopped, the child will be monitored for iatrogenic withdrawal syndrome, which refers to symptoms that can occur when the body adjusts to decreased medication levels after prolonged use.

The occurrence and severity of any withdrawal symptoms will be documented.

The total length of the child’s stay in the pediatric intensive care unit will be recorded in days.

The medical team will document the child’s overall condition and any complications that occur during this period.

After leaving the intensive care unit, the length of the child’s remaining hospital stay will be measured in days.

The child’s recovery progress will continue to be monitored until discharge from the hospital.

Information about the child’s health status will be collected for up to three months following the initial treatment.

This follow-up period allows for assessment of longer-term outcomes related to the sedation treatment received during intensive care.